{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:22:54Z","timestamp":1794428574440,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbrc.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:09:56Z","timestamp":1605244196000},"page":"773-779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function"],"prefix":"10.1016","volume":"534","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-6400","authenticated-orcid":false,"given":"January M.","family":"Watters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-6831","authenticated-orcid":false,"given":"Gabriela","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2951-5748","authenticated-orcid":false,"given":"Kenneth L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.11.001_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.11.001_bib2","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"Forstpointner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.11.001_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/JCO.2005.04.164","article-title":"Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)","volume":"23","author":"Ghielmini","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib4","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1200\/JCO.2005.01.1825","article-title":"High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine","volume":"23","author":"Romaguera","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib5","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.11.001_bib6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib7","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12885-016-2807-y","article-title":"The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways","volume":"16","author":"Hrgovic","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.bbrc.2020.11.001_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exphem.2004.09.008","article-title":"Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines","volume":"33","author":"Sakajiri","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib10","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/leu.2010.157","article-title":"HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells","volume":"24","author":"Shimizu","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.11.001_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s12272-015-0571-1","article-title":"Histone deacetylase inhibitors in hematological malignancies and solid tumors","volume":"38","author":"Chun","year":"2015","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrc.2020.11.001_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2020.11.001_bib13","doi-asserted-by":"crossref","first-page":"45266","DOI":"10.1038\/srep45266","article-title":"The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3","volume":"7","author":"Ni","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.11.001_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1189\/jlb.0711339","article-title":"Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression","volume":"91","author":"Rossi","year":"2012","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.11.001_bib16","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.1001682","article-title":"PRDM1\/Blimp-1 controls effector cytokine production in human NK cells","volume":"185","author":"Smith","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molimm.2017.08.016","article-title":"Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival","volume":"91","author":"Alexander","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2008.9","article-title":"A\u00a0novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas","volume":"22","author":"Balasubramanian","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.11.001_bib19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2020.11.001_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molonc.2011.08.001","article-title":"Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in\u00a0vitro and more aggressive tumors in\u00a0vivo","volume":"5","author":"Conrotto","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bbrc.2020.11.001_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1476-4598-9-187","article-title":"SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies","volume":"9","author":"Gustavsson","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.bbrc.2020.11.001_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle","volume":"489","author":"Deardorff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.11.001_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.molcel.2017.10.009","article-title":"Smc3 deacetylation by Hos1 facilitates efficient dissolution of sister chromatid cohesion during early anaphase","volume":"68","author":"Li","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2020.11.001_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK cells and cancer: you can teach innate cells new tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2020.11.001_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood-2004-09-3775","article-title":"DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction","volume":"106","author":"Adam","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.11.001_bib26","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/eji.200636290","article-title":"NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion","volume":"36","author":"Morandi","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib27","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2012-07-441022","article-title":"SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia\/lymphoma","volume":"121","author":"Higuchi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.11.001_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study","volume":"166","author":"Nordstrom","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2020.11.001_bib29","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma","volume":"119","author":"Nygren","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.11.001_bib30","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1093\/hmg\/ddu002","article-title":"Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance","volume":"23","author":"Kaiser","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.11.001_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","article-title":"Epigenetic control of skull morphogenesis by histone deacetylase 8","volume":"23","author":"Haberland","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2020.11.001_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.270","article-title":"Clinical utility gene card for: Cornelia de Lange syndrome","volume":"23","author":"Ramos","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2020.11.001_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.11.001_bib34","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1038\/cddis.2015.24","article-title":"Selective inhibition of HDAC8 decreases neuroblastoma growth in\u00a0vitro and in\u00a0vivo and enhances retinoic acid-mediated differentiation","volume":"6","author":"Rettig","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2020.11.001_bib35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma","volume":"4","author":"Chiron","year":"2014","journal-title":"Canc. Discov."},{"key":"10.1016\/j.bbrc.2020.11.001_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.11.001_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41591-018-0243-z","article-title":"Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma","volume":"25","author":"Agarwal","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.11.001_bib38","doi-asserted-by":"crossref","first-page":"14920","DOI":"10.1038\/ncomms14920","article-title":"Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.11.001_bib39","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20320441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20320441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:08:58Z","timestamp":1757765338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20320441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"alternative-id":["S0006291X20320441"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.001","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}